Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Tax Disclosure [Abstract]
Provision for income tax	$ 15	$ 5
Effective income tax rate	(0.20%)	(0.10%)

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.